Literature DB >> 2808537

Extracellular matrix: differential influence on growth and biosynthesis patterns of vascular smooth muscle cells from SHR and WKY rats.

T Scott-Burden1, T J Resink, M Bürgin, F R Bühler.   

Abstract

Smooth muscle cells from spontaneously hypertensive rats (SHR) elaborated extracellular matrix (ECM) material in culture that was more stimulatory to growth of cells from normotensive (WKY) animals than their own matrix. Both cell types elaborated ECMs consisting of glycoconjugate material (proteoglycans, glycopeptides) elastin, and collagens, but there were differences in the relative proportions of the compounds synthesized. Cells from SHR produced an ECM richer in elastin than that synthesized by WKY derived cells (approximately 19% vs. 11%, respectively). However, the latter elaborated ECMs containing more (approximately 45% for WKY vs. 29% for SHR) glycoconjugate material than the former. The lysyloxidase-mediated cross-linking of elastin was more rapid in cultured cells from SHR animals than from their normotensive counterparts and may be as a consequence of increased substate (tropoelastin) availability in ECMs from SHR animals. The relative proportions and sulphate levels of the glycosaminoglycans associated with matrix material elaborated by the two cell types were similar. Radiolabelled glycoconjugate material was degraded by cells (SHR/WKY) when they were plated upon pre-formed ECMs, and their patterns of synthesis of new matrix was markedly altered under such conditions. New matrix material elaborated by cells plated upon ECM-coated dishes consisted predominantly of glycopeptide and proteoglycan matrix components. Epidermal growth factor promoted the incorporation of [3H]-thymidine into DNA by quiescent cells, and this was also markedly stimulated when cells were plated onto ECM-coated plasticware rather than onto plastic substratum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808537     DOI: 10.1002/jcp.1041410206

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response.

Authors:  Akira Andoh; Shigeki Bamba; Yoshihide Fujiyama; Mairi Brittan; Nicholas A Wright
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

Review 2.  Regulation of smooth muscle cell growth by endothelium-derived factors.

Authors:  T Scott-Burden; P M Vanhoutte
Journal:  Tex Heart Inst J       Date:  1994

3.  Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II.

Authors:  E J Mackie; T Scott-Burden; A W Hahn; F Kern; J Bernhardt; S Regenass; A Weller; F R Bühler
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

4.  A line of rat ovarian surface epithelium provides a continuous source of complex extracellular matrix.

Authors:  P A Kruk; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-04       Impact factor: 2.416

5.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

6.  Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta.

Authors:  R A Majack; M W Majesky; L V Goodman
Journal:  J Cell Biol       Date:  1990-07       Impact factor: 10.539

7.  Small peptide functionalized thiol-ene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition.

Authors:  Sarah T Gould; Nicole J Darling; Kristi S Anseth
Journal:  Acta Biomater       Date:  2012-05-17       Impact factor: 8.947

8.  Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells.

Authors:  Melinda C Cushing; Peter D Mariner; Jo-Tsu Liao; Evan A Sims; Kristi S Anseth
Journal:  FASEB J       Date:  2008-01-24       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.